TP53 and cancer: Thus, the DNA damage response elicited through the p53/p21axes may depend on the metabolic and regulatory features of different cancer cells, tightly linked to development of chemoresistant cells through the complex and fragmentary characterized network of regulatory interactions associated with p53/p21pathway.